A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Clinical trial NCT01333865 · COMPLETED
Trial details
- NCT number
- NCT01333865
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2014-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.